Mimedx (MDXG) Receivables - Net (2016 - 2025)
Mimedx's Receivables - Net history spans 15 years, with the latest figure at $84.4 million for Q4 2025.
- For Q4 2025, Receivables - Net rose 51.2% year-over-year to $84.4 million; the TTM value through Dec 2025 reached $84.4 million, up 51.2%, while the annual FY2025 figure was $84.4 million, 51.2% up from the prior year.
- Receivables - Net for Q4 2025 was $84.4 million at Mimedx, up from $83.6 million in the prior quarter.
- Across five years, Receivables - Net topped out at $84.4 million in Q4 2025 and bottomed at $35.4 million in Q1 2021.
- The 5-year median for Receivables - Net is $50.1 million (2023), against an average of $52.2 million.
- The largest annual shift saw Receivables - Net grew 1.12% in 2022 before it skyrocketed 54.73% in 2025.
- A 5-year view of Receivables - Net shows it stood at $40.4 million in 2021, then grew by 6.77% to $43.1 million in 2022, then rose by 25.04% to $53.9 million in 2023, then rose by 3.63% to $55.8 million in 2024, then surged by 51.2% to $84.4 million in 2025.
- Per Business Quant, the three most recent readings for MDXG's Receivables - Net are $84.4 million (Q4 2025), $83.6 million (Q3 2025), and $73.2 million (Q2 2025).